| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.06 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |